中文名称: | 尼麦角林 | ||||
---|---|---|---|---|---|
英文名称: | Nicergoline | ||||
别名: | 麦角溴烟酯;尼什枸宁 Nicergoline | ||||
CAS No: | 27848-84-6 | 分子式: | C24H26BrN3O3 | 分子量: | 484.39 |
CAS No: | 27848-84-6 | ||||
分子式: | C24H26BrN3O3 | ||||
分子量: | 484.39 | ||||
MDL: | MFCD00869626 | EINEC: | 248-694-6 | ||
EINEC: | 248-694-6 |
基本信息
产品编号: |
N10703 |
||||
产品名称: |
Nicergoline |
||||
CAS: |
27848-84-6 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
分子量: |
484.39 |
-20℃ |
1个月 |
||
化学名: |
|||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
22mg/mL (45.41mM) |
|||
Ethanol |
|
||||
Water |
|
||||
体内(现配现用): |
|
||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
2.0645mL |
10.3223mL |
20.6445mL |
5mM |
0.4129mL |
2.0645mL |
4.1289mL |
10mM |
0.2064mL |
1.0322mL |
2.0645mL |
生物活性
产品描述 |
一种有效,选择性和具有口服活性的 α1A-肾上腺素能受体拮抗剂。Nicergoline 具有血管舒张作用。Nicergoline 可以改善阿尔茨海默症小鼠的认知功能。 |
|
靶点 |
α1A-adrenoceptor |
|
体外研究 |
Nicergoline (0.3-30μM;24h) attenuates activated microglia- and astrocytes-induced neuronal cell death.Nicergoline (0.3-30μM;48h) suppresses the production of proinflammatory cytokines and superoxide anion by activated microglia. |
|
体内研究 |
Nicergoline (10mg/kg;i.v.once daily for 60 d) improves impaired neurogenesis and cognitive competence in mice with Alzheimer's disease.Nicergoline (10mg/kg;i.v.once daily for 60 d) inhibits apoptosis,inflammation and oxidative stress in hippocampal cells,and regulates the activity of hippocampal cells through the PI3K/AKT signaling pathway in mice. |
|
Animal Model: |
3×Tg-AD mice (male,28-35g,6 weeks) with the Alzheimer's disease |
|
Dosage: |
10mg/kg |
|
Administration: |
I.v.once daily for 60 days |
|
Result: |
Improved neurogenesis and cognitive competence.Decreased the degree of dementia.Downregulated pathogenic Aβ-42 and-40 peptides and APP in the hippocampi.Increased Levels of the neuroprotective forkhead box protein P2 (Foxp2),Src homology 2- containing inositol phosphatase (SxIP) and end-binding proteins (EB) in the hippocampi.Exhibited marked differences in the dispersion of the pyramidal cell layer between the nicergoline-treated and control groups. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )